GB9910119D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number: GB9910119D0
Authority: GB; United Kingdom
Prior art keywords: organic compounds; compounds; organic
Prior art date: 1999-04-30
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB9910119.8A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Novartis AG

Original Assignee

Novartis AG

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-30

Filing date

1999-04-30

Publication date

1999-06-30

1999-04-30 Application filed by Novartis AG filed Critical Novartis AG

1999-04-30 Priority to GBGB9910119.8A priority Critical patent/GB9910119D0/en

1999-06-30 Publication of GB9910119D0 publication Critical patent/GB9910119D0/en

2000-04-26 Priority to PCT/EP2000/003708 priority patent/WO2000066724A2/en

2000-04-26 Priority to EP00925239A priority patent/EP1181361A2/en

2000-04-26 Priority to AU44025/00A priority patent/AU4402500A/en

Status Ceased legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1135—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against oncogenes or tumor suppressor genes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/341—Gapmers, i.e. of the type ===---===
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/34—Spatial arrangement of the modifications
- C12N2310/346—Spatial arrangement of the modifications having a combination of backbone and sugar modifications

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Genetics & Genomics (AREA)
Organic Chemistry (AREA)
Biomedical Technology (AREA)
Chemical & Material Sciences (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Bioinformatics & Cheminformatics (AREA)
Zoology (AREA)
Physics & Mathematics (AREA)
General Chemical & Material Sciences (AREA)
Plant Pathology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB9910119.8A 1999-04-30 1999-04-30 Organic compounds Ceased GB9910119D0 (en)

Priority Applications (4)

Application Number	Priority Date	Filing Date	Title
GBGB9910119.8A GB9910119D0 (en)	1999-04-30	1999-04-30	Organic compounds
PCT/EP2000/003708 WO2000066724A2 (en)	1999-04-30	2000-04-26	Oligonucleotide derivatives directed against human bcl-xl and human bcl-2 mrna
EP00925239A EP1181361A2 (en)	1999-04-30	2000-04-26	Oligonucleotide derivatives directed against human bcl-xl and human bcl-2 mrna
AU44025/00A AU4402500A (en)	1999-04-30	2000-04-26	Oligonucleotide derivatives directed against human bcl-xl and human bcl-2 mrna

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB9910119.8A GB9910119D0 (en)	1999-04-30	1999-04-30	Organic compounds

Publications (1)

Publication Number	Publication Date
GB9910119D0 true GB9910119D0 (en)	1999-06-30

Family

ID=10852654

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB9910119.8A Ceased GB9910119D0 (en)	1999-04-30	1999-04-30	Organic compounds

Country Status (4)

Country	Link
EP (1)	EP1181361A2 (en)
AU (1)	AU4402500A (en)
GB (1)	GB9910119D0 (en)
WO (1)	WO2000066724A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2832154B1 (en) *	2001-11-09	2007-03-16	Centre Nat Rech Scient	OLIGONUCLEOTIDES INHIBITORS AND THEIR USE FOR SPECIFICALLY REPRESSING A GENE
DE10258677A1 (en) *	2002-12-13	2004-06-24	Elez, Vera, Dr.	Combined use of antisense oligonucleotides for treating cancer, directed against the Polo-like kinase 1 and B cell leukemia/lymphoma 2 genes, having a synergistic effect
FR2852606A1 (en) *	2003-03-18	2004-09-24	Inst Nat Sante Rech Med	In vitro method for simultaneous inhibition of several genes, useful for treating cancer or viral infection, using a ligand that binds to a common site in the genes and induces cutting by topoisomerase
CN110623956A (en)	2014-01-28	2019-12-31	巴克老龄化研究所	Methods and compositions for killing senescent cells and for treating senescence-associated diseases and disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5470974A (en) *	1985-03-15	1995-11-28	Neu-Gene Development Group	Uncharged polynucleotide-binding polymers
DE69434209D1 (en) *	1993-09-20	2005-02-03	Univ Pennsylvania	REGULATION OF GENE EXPRESSION OF bcl-2
WO1995031470A2 (en) *	1994-05-13	1995-11-23	Merck Frosst Canada Inc.	Antisense inhibitors of gene expression
US5874566A (en) *	1996-10-25	1999-02-23	Hisamitsu Pharmaceutical Co. Inc.	Il-15 triplex oligonucleotides
WO2000001393A2 (en) *	1998-07-02	2000-01-13	The Trustees Of Columbia University In The City Of New York	OLIGONUCLEOTIDE INHIBITORS OF bcl-xL
US6214986B1 (en) *	1998-10-07	2001-04-10	Isis Pharmaceuticals, Inc.	Antisense modulation of bcl-x expression

1999
- 1999-04-30 GB GBGB9910119.8A patent/GB9910119D0/en not_active Ceased
2000
- 2000-04-26 WO PCT/EP2000/003708 patent/WO2000066724A2/en not_active Application Discontinuation
- 2000-04-26 AU AU44025/00A patent/AU4402500A/en not_active Abandoned
- 2000-04-26 EP EP00925239A patent/EP1181361A2/en not_active Withdrawn

Also Published As

Publication number	Publication date
EP1181361A2 (en)	2002-02-27
AU4402500A (en)	2000-11-17
WO2000066724A2 (en)	2000-11-09
WO2000066724A3 (en)	2001-02-08

Publication	Publication Date	Title
GB9903759D0 (en)	1999-04-14	Organic compounds
GB9903547D0 (en)	1999-04-07	Organic compounds
GB9907097D0 (en)	1999-05-19	Organic compounds
GB9908533D0 (en)	1999-06-09	Organic compounds
GB9903548D0 (en)	1999-04-07	Organic compounds
GB9902938D0 (en)	1999-03-31	Organic compounds
GB9907908D0 (en)	1999-06-02	Organic compounds
GB9910119D0 (en)	1999-06-30	Organic compounds
GB9910965D0 (en)	1999-07-14	Organic compounds
GB9911059D0 (en)	1999-07-14	Organic compounds
GB9910319D0 (en)	1999-06-30	Organic compounds
GB9903544D0 (en)	1999-04-07	Organic compounds
GB9903440D0 (en)	1999-04-07	Organic compounds
GB9902940D0 (en)	1999-03-31	Organic compounds
GB9902939D0 (en)	1999-03-31	Organic compounds
GB9903546D0 (en)	1999-04-07	Organic compounds
GB9901939D0 (en)	1999-03-17	Organic compounds
GB9900293D0 (en)	1999-02-24	Organic compounds
GB9900230D0 (en)	1999-02-24	Organic compounds
GB9903761D0 (en)	1999-04-14	Organic compounds
GB9912071D0 (en)	1999-07-21	Organic compounds
GB9911926D0 (en)	1999-07-21	Organic compounds
GB9903876D0 (en)	1999-04-14	Organic compounds
GB9907822D0 (en)	1999-06-02	Organic compounds
GB9903878D0 (en)	1999-04-14	Organic compounds

Legal Events

Date	Code	Title	Description
2000-05-03	COOA	Change in applicant's name or ownership of the application
2000-12-20	AT	Applications terminated before publication under section 16(1)